Electrochemotherapy has been demonstrated to be an effective treatment
for cutaneous cancers. The treatment includes administering a chemoth
erapeutic agent followed by electric pulses which are applied directly
to the tumour. The pulses facilitate delivery of drug through the pla
sma membrane. Enhanced delivery Is restricted to the area that has bee
n electrically treated. Currently, electrochemotherapy is administered
as a single treatment. Complete response rates are high; however, par
tial responses are obtained in a fraction of the treated tumours. An i
ssue associated with this is whether or not multiple treatments would
result in an improved therapy for these partially responding tumours.
A multiple treatment electrochemotherapy study was implemented in orde
r to address this issue. The study utilized subcutaneously induced mur
ine B16 melanoma tumours in C57B1/6 mice. Results showed large tumour
volume reductions in multiple treatment groups. In addition, a twofold
increase in tumour doubling time and greater percentages of complete
responses were found as a result of multiple treatment. These results
will be utilized to augment existing clinical trials with respect to r
etreating tumours that have partially responded to a single electroche
motherapy treatment.